Insider Title Company Date Price Return Shares Value
Kush Arvind Non-Executive Director Inhibikase Therapeutics, Inc. (IKT) 2024-10-21 $1.37 0.0% 145,000 $198,650
Return Profit / (loss) Cost
Total 0.0% $0 $198,650